Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by Bigkahuna57on Oct 26, 2024 11:21am
272 Views
Post# 36283332

Seriously? 3:1

Seriously? 3:1@TommyN, Dude!?1 Please - get a grip. What advantage, on this exchange would a 3:1 reverse split create?  None. I can't follow your suggestions, other than you prefer to see the share price lower. Save your breath. Without the required buyer(s) to maintain a higher SP - AND the cross trading, it will find its own level. 

Further, TLT won't go to the NASDAQ all by itself. It will be b/c of a BO, or merger.  It takes a lot of buying to support the SP on the NASDAQ, b/c typically new members are greeted with a shorting barrage. The most likely option would be a license agreement for each individual indication/type of cancer and/or virus and stay on this exchange until a BO. But, Roger et al will not be selling for a few $B. 

We're quite aware what TLT needs. The near-future events whether a PP, government grant or license agreement - will somehow get us down the road. 

If trying to talk down the SP is your strategy, rethink it. You're not enhancing what you may think is your credibility by predicting or suggesting obvious/rediculous statements. 

Until you buy back in, b/c you're a genius at buying low and selling high - go get a hobbie and don't tell us about it.

GLTA
Regards, BK
<< Previous
Bullboard Posts
Next >>